Literature DB >> 19039512

Serum N-terminal pro-brain natriuretic peptide, a marker of skin thickness in systemic sclerosis?

Nicoletta Carlo-Stella, Laura Belloli, Maria Luisa Biondi, Bianca Marasini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19039512     DOI： 10.1007/s10067-008-1048-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  7 in total

1.  The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients.

Authors:  Hyo Jin Choi; Young Kee Shin; Hyun Joo Lee; Joo Young Kee; Dong Woo Shin; Eun Young Lee; Yun Jong Lee; Eun Bong Lee; Yeong Wook Song
Journal:  Clin Rheumatol       Date:  2007-09-25       Impact factor: 2.980

2.  Increased cardiac BNP expression associated with myocardial ischemia.

Authors:  J P Goetze; C Christoffersen; M Perko; H Arendrup; J F Rehfeld; J Kastrup; L B Nielsen
Journal:  FASEB J       Date:  2003-04-22       Impact factor: 5.191

3.  Natriuretic peptide system gene expression in human coronary arteries.

Authors:  Victor H Casco; John P Veinot; Mercedes L Kuroski de Bold; Roy G Masters; Michelle M Stevenson; Adolfo J de Bold
Journal:  J Histochem Cytochem       Date:  2002-06       Impact factor: 2.479

4.  Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial.

Authors:  P J Clements; E L Hurwitz; W K Wong; J R Seibold; M Mayes; B White; F Wigley; M Weisman; W Barr; L Moreland; T A Medsger; V D Steen; R W Martin; D Collier; A Weinstein; E Lally; J Varga; S R Weiner; B Andrews; M Abeles; D E Furst
Journal:  Arthritis Rheum       Date:  2000-11

5.  Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts.

Authors:  Peng Li; Dajun Wang; Jason Lucas; Suzanne Oparil; Dongqi Xing; Xu Cao; Lea Novak; Matthew B Renfrow; Yiu-Fai Chen
Journal:  Circ Res       Date:  2007-11-08       Impact factor: 17.367

6.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

7.  Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion.

Authors:  William E Hopkins; Zengyi Chen; Naomi K Fukagawa; Christian Hall; Harm J Knot; Martin M LeWinter
Journal:  Circulation       Date:  2004-06-01       Impact factor: 29.690
  7 in total
  3 in total

Review 1.  N-TproBNP as biomarker in systemic sclerosis.

Authors:  Tommaso Schioppo; Carolina Artusi; Teresa Ciavarella; Francesca Ingegnoli; Antonella Murgo; Silvana Zeni; Cecilia Chighizola; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

Review 2.  Systemic sclerosis and the heart: current diagnosis and management.

Authors:  Chintan S Desai; Daniel C Lee; Sanjiv J Shah
Journal:  Curr Opin Rheumatol       Date:  2011-11       Impact factor: 5.006

3.  Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis.

Authors:  Chiara Bellocchi; Jun Ying; Ellen A Goldmuntz; Lynette Keyes-Elstein; John Varga; Monique E Hinchcliff; Marka A Lyons; Peter McSweeney; Daniel E Furst; Richard Nash; Leslie J Crofford; Beverly Welch; Jonathan G Goldin; Ashley Pinckney; Maureen D Mayes; Keith M Sullivan; Shervin Assassi
Journal:  Arthritis Rheumatol       Date:  2021-02-28       Impact factor: 10.995
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.